ATLAS / Macro Radar / Reporting / ANRO

Alto Neuroscience, Inc. (ANRO) reporting calendar

Alto Neuroscience, Inc. files periodic reports with the SEC as ANRO on NYSE. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 31 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
13 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ANRO market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll NYSE reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202613 May 202643 days0001999480-26-000012
10-K31 Dec 202516 Mar 202675 days0001999480-26-000002
10-Q30 Sep 202512 Nov 202543 days0001999480-25-000090
10-Q30 Jun 202513 Aug 202544 days0001999480-25-000076
10-Q31 Mar 202514 May 202544 days0001999480-25-000037
10-K31 Dec 202420 Mar 202579 days0001999480-25-000025
10-Q30 Sep 202412 Nov 202443 days0001999480-24-000042
10-Q30 Jun 202413 Aug 202444 days0001999480-24-000035
10-Q31 Mar 202414 May 202444 days0001999480-24-000022
10-K31 Dec 202321 Mar 202481 days0001999480-24-000010

Source: SEC EDGAR company submissions for CIK 0001999480. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.